Latest News
WeWork revenues and losses soar as global expansion ramps up
New York’s WeWork revealed that revenues doubled last year to nearly $2bn – but losses also widened significantly.
US open: Stocks go green amidst a slew of data releases
US stocks opened higher on Tuesday as investors thumbed over a slew of data releases.
Investors send Carnival to the bottom after company cuts full-year guidance
Investors marked down shares of Carnival after the cruise line operator cut its guidance for full-year earnings per share, blaming higher fuel costs and headwinds in currency markets for the shortfall.
Samsung warns first-quarter earnings will miss forecasts
Samsung Electronics surprised markets after warning that first-quarter earnings would come in below expectations.
LiDCO jumps as new business model leaves it 'well positioned'
LiDCO Group's shares climbed on Tuesday as the outfit reported that it is "well positioned for strong growth" following good progress with a new business model, despite recording a drop in annual revenue.
Tuesday broker round-up
Spectris: Goldman Sachs downgrades to sell with a target price of 2,200p.
Pound up on hopes of softening opposition to May's Brexit deal
Sterling rallied on Tuesday, on speculation that hard-line Brexiteers were starting to come around to Theresa May’s withdrawal deal.
US house price growth eases in January - S&P/Case-Shiler
US house price growth came in a little weaker than expected in January, according to the S&P/Case-Shiller National Home Price Index.
Ocado hits new high as bags contract with Australia's Coles
Ocado has won a contract to develop an online grocery business for Australian supermarket and liquor store operator Coles Group.
US housing starts drop more than expected in February
US housing starts declined more than expected in February, according to figures released by the Commerce Department on Tuesday.
Spectris slumps on Goldman Sachs downgrade
Spectris was under the cosh on Tuesday as Goldman Sachs cut its recommendation to 'sell' from 'neutral' as it forecasts weak sector-relative growth, returns and cash conversion over the next two years despite the stock being valued at a premium to the sector.
Vianet trades 'largely as anticipated'
Technology-based data and business insight provider Vianet expects full-year profits to be in line with market expectations and ahead of the previous year after trading "largely as anticipated".
SolGold advances preliminary economic analysis at Alpala
Explorer SolGold's preliminary economic analysis on its Alpala project has progressed to "a very advanced stage", with the company now expecting to complete and release its report following peer review and QAQC procedures.
Cadence Minerals raises £1.3m to fund Australian exploration programme
Cadence Minerals raised £1. 3m through a placing of 866m ordinary shares on Tuesday in order to fund an initial exploration programme across its Australian lithium assets.
Activists take aim at Bed Bath and Beyond, shares surge in pre-market trading
Bed Bath and Beyond shares soared ahead of the opening bell on Wall Street after news that activist investors were trying to oust the retailer's entire board.
Apple's starry TV launch fails to prevent analyst disappointment
Apple’s long-awaited services update included a television streaming service, a virtual games arcade, a 'Spotify for news' and a titanium credit card but failed to wow investors and analysts.
ECB's Rehn says policy to remain accommodative for 'quite some time'
A top European Central Bank official said on Tuesday that the current slowdown in the Eurozone economy might be more protracted than what had been expected just a few months before and that monetary policy would need to remain accommodative for "quite some time".
Alliance Pharma climbs as overseas business gathers steam
Alliance Pharma's shares climbed on Tuesday as annual revenues climbed after its performance was boosted by acquisitions and international business, with overseas sales overtaking domestic revenues for the first time.
Pelatro profits double as acquisition boosts recurring revenues
Pelatro on Tuesday reported that annual profits more than doubled as revenue soared as the acquisition of Danateq's assets resulted in a jump in repeat sales.
Europe midday: Stocks find a bid, but defensive pharma in the lead
Stocks on the Continent are bouncing back despite a mixed set of economic data, with global growth fears - stoked by recent sharp falls in US government bond yields - apparently easing.